Fibroadipose vascular anomaly treated with sirolimus: Successful outcome in two patients

Jonathan Erickson, William McAuliffe, Lewis Blennerhassett, Anne Halbert

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)

Abstract

Fibroadipose vascular anomaly (FAVA) is a rare, complex mesenchymal malformation combining fibrofatty replacement of the affected muscles and slow-flow vascular malformation. The condition is characterized by localized swelling, severe pain, phlebectasia, and contracture of the affected limb. Treatment paradigms are not well established for this rare, recently recognized condition. We report two cases of FAVA in which treatment with sirolimus produced rapid, dramatic improvement in pain and quality of life.

Original languageEnglish
Pages (from-to)E317-E320
Number of pages4
JournalPediatric Dermatology
Volume34
Issue number6
DOIs
Publication statusPublished - 2017
Externally publishedYes

Fingerprint

Dive into the research topics of 'Fibroadipose vascular anomaly treated with sirolimus: Successful outcome in two patients'. Together they form a unique fingerprint.

Cite this